Company Overview

Ethema Health Corporation is a publicly traded company focused on the cannabis and hemp-derived products industry, with activities spanning cultivation, processing, and health-oriented cannabinoid applications. The company positions itself at the intersection of cannabis production and health research, with an emphasis on leveraging regulated markets and scientific validation to support its business model. Its operations have historically targeted both the medical and adult-use cannabis markets, as well as hemp-derived cannabinoid opportunities.

Originally incorporated as GreenStar Biosciences Corp., the company rebranded to Ethema Health Corporation as part of a strategic shift toward health-focused cannabis research and development. The evolution reflects an effort to differentiate through clinical research, intellectual property development, and partnerships rather than purely commodity cannabis cultivation. Public disclosures indicate that revenue generation has been limited and inconsistent, and the company has frequently relied on asset sales, restructurings, and strategic pivots to sustain operations. Data inconclusive based on available public sources regarding the current scale of commercial revenues.

Business Operations

Ethema Health Corporation has historically reported operations across cannabis cultivation, hemp processing, and cannabinoid research initiatives. Its business activities have included ownership or control of cultivation assets, intellectual property related to cannabinoid formulations, and early-stage health research programs. The company has also disclosed interests in clinical research-oriented cannabis programs, though the commercialization status of these initiatives remains limited based on public filings.

Operations have been conducted through a mix of direct ownership and subsidiary structures, with activities spanning North America. The company has disclosed past and present subsidiaries associated with cannabis cultivation and hemp processing; however, several assets have been impaired, divested, or placed into inactive status over time. Based on recent publicly available disclosures, the operational footprint appears materially smaller than during earlier expansion phases, and some operational claims cannot be independently confirmed beyond company filings.

Strategic Position & Investments

Strategically, Ethema Health Corporation has emphasized a transition toward health-focused cannabinoid research, including potential clinical validation and intellectual property development. Growth initiatives described in public disclosures have included pursuing regulated medical cannabis markets, research collaborations, and selectively acquiring or developing assets aligned with health and wellness applications of cannabinoids.

The company has announced and completed various acquisitions and divestitures over its history, often restructuring its portfolio to reduce capital intensity. Notable investments have included cannabis cultivation facilities and hemp-related processing assets, though several of these have been written down or exited. Public information indicates ongoing interest in emerging cannabinoid applications, but there is insufficient verified data to confirm active late-stage clinical programs or material investment positions at present.

Geographic Footprint

Ethema Health Corporation’s operations and corporate activities have primarily been centered in North America, with historical operational exposure in Canada and the United States. Canada has served as a base for cannabis-related activities due to its federally regulated cannabis framework, while U.S. activities have focused more on hemp-derived products and corporate development.

The company is headquartered in Canada, with its common stock quoted on the OTC Markets in the United States under the ticker GRST. International operations outside North America have been referenced intermittently in disclosures, but there is no verified evidence of sustained operational presence or material revenue generation in other regions.

Leadership & Governance

Ethema Health Corporation is led by a small executive team, with governance and management frequently evolving in response to restructuring efforts and strategic changes. Leadership has emphasized capital preservation, regulatory compliance, and repositioning toward health-oriented cannabis opportunities.

Key executives disclosed in recent public filings include:

• Sean McGrath – Chief Executive Officer
• Ryan M. Fishoff – Chief Financial Officer
• Leonard J. Mazur – Chairman of the Board

The leadership philosophy articulated in public communications centers on disciplined capital allocation, asset rationalization, and the pursuit of differentiated cannabinoid-based health solutions. Frequent management and board changes over time suggest an organization in transition, and long-term strategic continuity remains difficult to assess based on available public data.